Latest Share Chat

REMOVE ADS

Celadon Pharmaceuticals Share News (CEL)

Celadon Pharmaceuticals Information

This share is currently suspended. It was suspended at a price of 13.40

There is currently no data for CEL

REMOVE ADS

Celadon Pharmaceuticals News

IN BRIEF: Celadon Pharmaceuticals formally confirms CFO appointment

Celadon Pharmaceuticals PLC - London-based pharmaceutical company focusing on cannabis-based medicines - Confirms Jonathan Turner will formally join t...

TRADING UPDATES: Lansdowne extends loan, Celadon plans clinical trial

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

TRADING UPDATES: Logistics Development buys Alliance Pharma shares

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and Thursday and not separately reported by Alli...

Celadon confident in approval for its cannabis medicine facility

(Sharecast News) - Cannabis-based medicine developer Celadon Pharmaceuticals updated the market on its application for registration of its West Midlan...

EXECUTIVE CHANGES: Former 600 CFO to return; Celadon hires new CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

EARNINGS UPDATES: Crestchic raises outlook on record year-to-date

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

UK earnings, trading statements calendar - next 7 days

IN BRIEF: Celadon Pharma finishes sixth harvest from cannabis facility

Celadon Pharmaceuticals PLC - London-based manufacturer and supplier of cannabinoid-based medicines formerly known as Summerway Capital PLC - Complete...